These guidelines for the biological treatment of schizophrenia were developed by an
international Task Force of the World Federation of Societies of Biological Psychiatry …

A structured interview and standardized rating scales were used to assess a sample of 194
outpatients with schizophrenia in a regional Australian mental health service for substance …

Empirical studies of cognitive functioning in patients suffering from schizophrenia and a
substance use disorder are lacking. Consensus exists that schizophrenia is a …

Estas diretrizes para o tratamento biológico da esquizofrenia foram desenvolvidas pela
Força-Tarefa da Federação Mundial das Sociedades de Psiquiatria Biológica (World …

In this chapter we discuss the effects of moderate ethanol consumption on the treatment of
psychiatric and sleep disorders. A review of the literature on the interactions of ethanol with …

Dieser kompetente Praxisleitfaden enthält alles, was man über die Arzneimitteltherapie von
Alkoholismus wissen muß. Dabei wird nicht nur auf die Wirkstoffe, sondern auch auf die …

Recent clinical and epidemiological studies have estimated that 20 to 58% of patients with
schizophrenia also have a diagnosis of substance abuse (ie have a 'dual diagnosis'). In …

Eight patients selected from a depot neuroleptic clinic in the hospital outpatients department
were assessed clinically on various demographic and clinical variables with a view to …

The treatment of patients with drug-resistant schizophrenia is a major challenge for both the
clinician and the patient, and requires systematic and comprehensive management. Patients …

Substance abuse co-occurs at high rates with schizophrenia, with alcohol as the most
commonly abused substance. Dual diagnoses have been associated with lower levels of …